The efficacy and safety of furazolidone-bismuth quadruple therapy for <i>Helicobacter pylori</i> eradication with or without probiotic supplementation.

Gastroenterol Hepatol Bed Bench · 2022 · PMC9275735 · PMID 35845306

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Total rate of adverse effects (including abdominal pain, nausea, vomiting, diarrhea, and palpitation) reported by patients was 30% in the probiotic group compared with 62% in the placebo group, but the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.